2025 European Society for Pediatric Dermatology (EPSD) Poster Presentation: Phase 2 trial of topical drug zabalafin treating mild to moderate atopic dermatitis
2025 European Society for Pediatric Dermatology (EPSD) Poster Presentation: Phase 2 trial of topical drug zabalafin treating mild to moderate atopic dermatitis, starting with infection in children and adults NEWS PROVIDED BY Alphyn Biologics May 29, 2025, 19:30 ET CONTACTS Corporate: Neal Koller nkoller@alphynbiologics.com (410) 690-8687 Media: Susan Thomas susan@endpointcommunications.net (619) 540-9195